Company Search:
Advanced Search
Sponsored Links
MorphoSys AG Company Snapshot
MorphoSys AG operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares MorphoSys AG with three other miscellaneous service companies in Europe: AddLife AB of Sweden (2015 sales of 1.06 billion Swedish Kronor [US$119.72 million] of which 98% was LabTech), Ablynx N.V. of Belgium (77.54 million Euro [US$85.11 million] of which 100% was Nanobodies), and Bavarian Nordic AS which is based in Denmark (1.02 billion Danish Kroner [US$150.59 million] of which 100% was Medical Research).

Sales Analysis. During the year ended December of 2015, sales at MorphoSys AG were 106.22 million Euro (US$116.60 million). This is an increase of 66.0% versus 2014, when the company's sales were 63.98 million Euro. Sales of Proprietary Development saw an increase that was more than double the company's growth rate: sales were up 298.5% in 2015, from 15.04 million Euro to 59.94 million Euro. Not all segments of MorphoSys AG experienced an increase in sales in 2015: sales of Partnered Discovery fell 5.4% to 46.28 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
MorphoSys AG
  Stock Performance Chart for MorphoSys AG
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 41.34
(Figures in Euro)
1 Week -4.6%   13 Weeks 14.4%  
4 Weeks 5.5%   52 Weeks -27.5%  
MorphoSys AG Key Data:
  Ticker: MOR Country: Germany
  Exchanges: DUS FRA OTH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 106,222,897
(Year Ending Jan 2016).
Employees: 365
  Currency: Euro Market Cap: 1,079,751,382
  Fiscal Yr Ends: December Shares Outstanding: 26,121,964
  Share Type: Stammaktie Closely Held Shares: 793,949
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.